Rocket Pharmaceuticals, Inc. Ratios

Ratios Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
EBT Margin 886.12%1,750.98%1,250.29%1,320.83%1,996.84%5,614.95%11,939.63%13,666.45%14,147.61%
EBIT Margin 786.12%1,658.21%1,178.27%1,278.13%1,927.70%5,618.00%12,048.50%13,848.48%14,485.95%
EBITDA Margin 786.12%1,658.21%1,178.27%1,278.13%1,927.70%5,618.00%12,048.50%13,848.48%14,485.95%
Operating Margin 786.12%1,658.21%1,178.27%1,278.13%1,927.70%5,618.00%12,048.50%13,848.48%14,485.95%
Net Margin 886.12%1,750.98%1,233.95%1,296.91%2,005.17%5,679.17%11,915.31%13,098.40%13,719.30%
FCF Margin -730.20%994.18%1,449.43%914.74%1,475.86%1,367.12%4,325.93%10,016.11%11,272.11%11,430.86%
Efficiency
Assets Average 74.90M135.73M311.72M481.47M543.92M524.41M559.07M547.02M
Equity Average 44.34M104.78M250.67M405.41M479.12M472.20M491.13M477.90M
Invested Capital 125.17M15.52M194.04M307.30M503.52M454.72M489.69M492.57M463.23M
Asset Utilization Ratio -0.04-0.02-0.01-0.010.000.000.00
Leverage & Solvency
Interest Coverage Ratio -7.86-16.58-11.78-12.78-19.28-56.18-120.48-138.48-144.86
Equity Ratio 0.560.770.770.830.850.910.890.870.88
Times Interest Earned -7.86-16.58-11.78-12.78-19.28-56.18-120.48-138.48-144.86
Valuation
Enterprise Value 299.23M37.80M52.91M384.63M842.44M2,507.45M1,018.04M1,124.75M2,328.89M773.51M
Market Capitalization 299.23M164.28M71.05M590.36M1,146.56M3,029.02M1,406.78M1,481.14M2,702.06M1,145.84M
Return Ratios
Return on Sales 8.86%17.51%12.50%13.21%19.97%56.15%119.40%136.66%141.48%
Return on Capital Employed -0.28%-0.59%-0.26%-0.30%-0.32%-0.46%-0.51%-0.54%
Return on Assets -0.26%-0.56%-0.25%-0.29%-0.31%-0.42%-0.46%-0.49%
Return on Equity -0.45%-0.72%-0.31%-0.34%-0.35%-0.47%-0.52%-0.56%